MINDY RATHE: Open Payments
NPI 1730270117 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$489 in 15 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $192 · 2025 $489
Food & beverage: $489
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $165 |
| Sumitomo Pharma America, Inc. | 5 | $100 |
| ABBVIE INC. | 4 | $82 |
| Astellas Pharma US Inc | 2 | $74 |
| Octapharma USA, Inc. | 1 | $35 |
| 180 Medical, Inc. | 1 | $19 |
| Exeltis, USA Inc. | 1 | $15 |
Products named: INTERSTIM, BOTOX, Veozah, MYFEMBREE, GEMTESA, FIBRYGA, SLYND.
Industry payments across NE — which companies pay providers there.
